Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0023052; signaling | GO:0060079; excitatory postsynaptic potential | 2.798E-12 | 5.540E-09 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
BP | GO:0051179; localization | GO:0034220; ion transmembrane transport | 1.130E-05 | 4.035E-03 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
BP | GO:0009987; cellular process | GO:0035235; ionotropic glutamate receptor signaling pathway | 5.447E-15 | 3.811E-11 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
CC | GO:0044464; cell part | GO:0043204; perikaryon | 8.490E-09 | 1.027E-05 | GRIK2, GRIK3, GRIK5, SMN1, SMN2 |
CC | GO:0044456; synapse part | GO:0045211; postsynaptic membrane | 1.778E-07 | 1.335E-04 | GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
CC | GO:0032991; macromolecular complex | GO:0032983; kainate selective glutamate receptor complex | 1.254E-06 | 6.561E-04 | GRIK2, GRIK5 |
CC | GO:0044464; cell part | GO:0043005; neuron projection | 6.386E-06 | 2.528E-03 | GRIA1, GRIA4, GRIK3, GRIK5, SMN1, SMN2 |
CC | GO:0044456; synapse part | GO:0043195; terminal bouton | 8.802E-06 | 3.305E-03 | GRIK2, GRIK3, GRIK5 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 2.749E-05 | 9.210E-03 | SMN1, SMN2 |
MF | GO:0005215; transporter activity | GO:0015277; kainate selective glutamate receptor activity | 6.163E-13 | 1.491E-09 | GRIK1, GRIK2, GRIK3, GRIK5 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa03013 | RNA transport_Homo sapiens_hsa03013 | 5.389E-03 | 1.557E-02 | SMN2; SMN1 |
hsa03440 | Homologous recombination_Homo sapiens_hsa03440 | 1.869E-02 | 4.860E-02 | BLM |
hsa04024 | cAMP signaling pathway_Homo sapiens_hsa04024 | 2.578E-04 | 1.950E-03 | GRIA1; TSHR; GRIA4 |
hsa04080 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.484E-12 | 3.858E-11 | GRIA1; GRIK5; ADORA3; GRIK3; GRIK1; GRIK2; TSHR; GRIA4 |
hsa04713 | Circadian entrainment_Homo sapiens_hsa04713 | 1.683E-03 | 7.055E-03 | GRIA1; GRIA4 |
hsa04723 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.899E-03 | 7.055E-03 | GRIA1; GRIA4 |
hsa04724 | Glutamatergic synapse_Homo sapiens_hsa04724 | 4.988E-11 | 6.484E-10 | GRIA1; GRIK5; GRIK3; GRIK1; GRIK2; GRIA4 |
hsa04728 | Dopaminergic synapse_Homo sapiens_hsa04728 | 3.074E-03 | 9.989E-03 | GRIA1; GRIA4 |
hsa05031 | Amphetamine addiction_Homo sapiens_hsa05031 | 8.420E-04 | 4.379E-03 | GRIA1; GRIA4 |
hsa05033 | Nicotine addiction_Homo sapiens_hsa05033 | 3.000E-04 | 1.950E-03 | GRIA1; GRIA4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Infections | A00-B99 | PTPN1 |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ADORA3 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Cancer | C00-C96 | ADORA3 |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | ADORA3 |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | PTPN1 |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | PTPN1 |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | ADORA3 |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | PTPN1; PTPN1 |